InvestorQ : Can you tell me about the Veeda Clinical IPO and what does it want to fund with the IPO?
Mahima Roy made post

Can you tell me about the Veeda Clinical IPO and what does it want to fund with the IPO?

Answer
image
3 months ago
Follow

Veeda Clinical Research has laid out plans to raise nearly Rs.700 crore through the IPO route. The IPO is expected to be a combination of fresh issue and an offer for sale or OFS. It is likely to file the DRHP shortly. Veeda Clinical is funded by CX partners as well as family office of Havells and by Sixth Sense Ventures.

Veeda focuses predominantly on bioavailability and bioequivalence (BA/BE) studies, which have been gaining a lot of traction due to a large number of drugs which will be going off-patent in the next 5-6 years. The BA/BE study is in demand for most generic companies looking to replicate branded drugs at a lower cost.

6 Views